301509 金凯生科
已收盘 08-23 15:00:00
资讯
新帖
简况
金凯生科:公司如获悉公司高管增持信息,将按规定履行信息披露义务
证券之星 · 08-23 18:04
金凯生科:公司如获悉公司高管增持信息,将按规定履行信息披露义务
金凯生科(301509)8月20日股东户数1.32万户,较上期减少9.61%
证券之星 · 08-21
金凯生科(301509)8月20日股东户数1.32万户,较上期减少9.61%
破发股金凯生科跌3.59%创新低 2023年上市超募3.1亿
中国经济网 · 08-19
破发股金凯生科跌3.59%创新低 2023年上市超募3.1亿
金凯生科SZ301509:首次解禁股份注意事项及规定解读
问董秘 · 08-16
金凯生科SZ301509:首次解禁股份注意事项及规定解读
金凯生科(301509)8月15日主力资金净卖出1091.90万元
证券之星 · 08-16
金凯生科(301509)8月15日主力资金净卖出1091.90万元
金凯生科(301509)8月13日主力资金净卖出1126.87万元
证券之星 · 08-14
金凯生科(301509)8月13日主力资金净卖出1126.87万元
金凯生科:截至2024年8月9日,公司股东总户数为14,631户
证券之星 · 08-13
金凯生科:截至2024年8月9日,公司股东总户数为14,631户
【金凯生科:巴斯夫火灾相关事件目前对公司销售无影响】金十数据8月13日讯,金凯生科8月13日在互动平台回应投资者“金凯生科为巴斯夫等跨国化工集团提供从产品试验到商业化应用所需农药中间体的配套研发和生产服务。
美港电讯 · 08-13
【金凯生科:巴斯夫火灾相关事件目前对公司销售无影响】金十数据8月13日讯,金凯生科8月13日在互动平台回应投资者“金凯生科为巴斯夫等跨国化工集团提供从产品试验到商业化应用所需农药中间体的配套研发和生产服务。
金凯生科(301509)8月8日主力资金净卖出1998.96万元
证券之星 · 08-09
金凯生科(301509)8月8日主力资金净卖出1998.96万元
A股异动丨金凯生科跌超6% 2662.93万股限售股今日解禁金凯生科(301509.SZ)跌幅扩大至超6%,现报32元,总市值38.
格隆汇 · 08-07
A股异动丨金凯生科跌超6% 2662.93万股限售股今日解禁金凯生科(301509.SZ)跌幅扩大至超6%,现报32元,总市值38.
A股医药股集体走弱 CRO方向领跌河化股份、百花医药跌停,睿智医药、双成药业、金凯生科、鲁抗医药、四环生物、舒泰神等多股跌超5%。
格隆汇 · 08-07
A股医药股集体走弱 CRO方向领跌河化股份、百花医药跌停,睿智医药、双成药业、金凯生科、鲁抗医药、四环生物、舒泰神等多股跌超5%。
76.46亿元市值限售股今日解禁,华虹公司、金凯生科、上海凤凰解禁市值居前周三(8月7日),共有8家公司限售股解禁,合计解禁量为2.
格隆汇 · 08-07
76.46亿元市值限售股今日解禁,华虹公司、金凯生科、上海凤凰解禁市值居前周三(8月7日),共有8家公司限售股解禁,合计解禁量为2.
76.46亿元市值限售股今日解禁,华虹公司、金凯生科、上海凤凰解禁市值居前
界面 · 08-07
76.46亿元市值限售股今日解禁,华虹公司、金凯生科、上海凤凰解禁市值居前
金凯生科(301509)2662.93万股限售股将于8月7日解禁,占总股本22.11%
证券之星 · 08-07
金凯生科(301509)2662.93万股限售股将于8月7日解禁,占总股本22.11%
金凯生科:公司会严格遵守IPO时签署的稳定股价的相关承诺
证券之星 · 08-06
金凯生科:公司会严格遵守IPO时签署的稳定股价的相关承诺
金凯生科(301509.SZ):2662.93万股限售股将于8月7日上市流通
智通财经 · 08-05
金凯生科(301509.SZ):2662.93万股限售股将于8月7日上市流通
【金凯生科(301509.SZ):2662.93万股限售股将于8月7日上市流通】智通财经APP讯,金凯生科(301509.
智通财经 · 08-05
【金凯生科(301509.SZ):2662.93万股限售股将于8月7日上市流通】智通财经APP讯,金凯生科(301509.
A股CRO概念震荡走强 河化股份5连板河化股份5连板,睿智医药涨超10%,百花医药、双成药业、金凯生科、美迪西、昭衍新药等跟涨。
格隆汇 · 08-05
A股CRO概念震荡走强 河化股份5连板河化股份5连板,睿智医药涨超10%,百花医药、双成药业、金凯生科、美迪西、昭衍新药等跟涨。
CRO板块持续活跃,睿智医药涨超11%,金凯生科、美迪西、泰格医药涨超2%。
智通财经 · 08-05
CRO板块持续活跃,睿智医药涨超11%,金凯生科、美迪西、泰格医药涨超2%。
金凯生科(301509)8月2日主力资金净卖出106.75万元
证券之星 · 08-05
金凯生科(301509)8月2日主力资金净卖出106.75万元
加载更多
公司概况
公司名称:
金凯(辽宁)生命科技股份有限公司
所属行业:
医药制造业
上市日期:
2023-08-03
主营业务:
金凯(辽宁)生命科技股份有限公司的主营业务为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司主要产品包括含氟类产品、非含氟类产品等。公司曾获得专精特新“小巨人”企业、高新技术企业、省级企业技术中心等。
发行价格:
56.56
{"stockData":{"symbol":"301509","market":"SZ","secType":"STK","nameCN":"金凯生科","latestPrice":26.12,"timestamp":1724396610000,"preClose":26.39,"halted":0,"volume":1248819,"delay":0,"floatShares":56740900,"shares":120000000,"eps":1.2425,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.27,"latestTime":"08-23 15:00:00","open":26.34,"high":26.45,"low":25.8,"amount":32560200,"amplitude":0.0246,"askPrice":26.14,"askSize":25,"bidPrice":26.12,"bidSize":3,"shortable":0,"etf":0,"ttmEps":1.2425,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":26.39,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":29.03,"lowLimit":23.75,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120446669,"pbRate":1.45,"roa":"--","roe":"0.77%","epsLYR":2.42,"committee":-0.242604,"marketValue":3146000000,"floatMarketCap":1482000000,"peRate":21.022134,"changeRate":-0.0102,"turnoverRate":0.022,"status":1},"requestUrl":"/m/hq/s/301509","defaultTab":"news","newsList":[{"id":"2461565345","title":"金凯生科:公司如获悉公司高管增持信息,将按规定履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2461565345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461565345?lang=zh_cn&edition=full","pubTime":"2024-08-23 18:04","pubTimestamp":1724407497,"startTime":"0","endTime":"0","summary":"证券之星消息,金凯生科08月23日在投资者关系平台上答复投资者关心的问题。公司会认真听取投资者建议,并根据法律法规相关规定结合多种因素综合考虑是否进行股份回购,如公司后续有相关计划,将会严格按照相关规定进行信息披露。公司二季度业绩尚未披露。公司如获悉公司高管增持信息,将按规定履行信息披露义务。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300035880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2461812827","title":"金凯生科(301509)8月20日股东户数1.32万户,较上期减少9.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461812827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461812827?lang=zh_cn&edition=full","pubTime":"2024-08-21 17:04","pubTimestamp":1724231062,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金凯生科披露,截至2024年8月20日公司股东户数为1.32万户,较8月9日减少1406.0户,减幅为9.61%。在医疗服务行业个股中,金凯生科股东户数低于行业平均水平,截至8月20日,医疗服务行业平均股东户数为4.43万户。从股价来看,2024年8月9日至2024年8月20日,金凯生科区间跌幅为10.31%,在此期间股东户数减少1406.0户,减幅为9.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100030293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2460702755","title":"破发股金凯生科跌3.59%创新低 2023年上市超募3.1亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2460702755","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460702755?lang=zh_cn&edition=full","pubTime":"2024-08-19 16:12","pubTimestamp":1724055120,"startTime":"0","endTime":"0","summary":"截至收盘,金凯生科报28.22元,跌幅3.59%,总市值33.99亿元。 金凯生科于2023年8月3日在深交所创业板上市,发行股份数量为2,150.8335万股,发行股份占本次发行后公司股份总数的比例为25.00%,发行价格为56.56元/股。 金凯生科本次发行募集资金总额121,651.14万元,扣除发行费用后募集资金净额约为111,074.43万元。 金凯生科本次公开发行新股的发行费用合计10,576.71万元,其中中信建投证券股份有限公司获得保荐及承销费用8,654.56万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-08-19/doc-inckehue4557590.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-08-19/doc-inckehue4557590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2459264879","title":"金凯生科SZ301509:首次解禁股份注意事项及规定解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2459264879","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459264879?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:00","pubTimestamp":1723795200,"startTime":"0","endTime":"0","summary":"投资者提问:公司8月7日解禁股是否减持完毕?董秘回答(金凯生科SZ301509):尊敬的投资者,您好!本次解禁股份为公司首次公开发行前发行的股份,持有本次解禁股份的大股东、特定股东若实施减持需要遵守《上市公司股东减持股份管理暂行办法》、《深圳证券交易所上市公司自律监管指引第18号——股东及董事、监事、高级管理人员减持股份》等规定,并需履行其在公司首次公开发行时所作出的相关承诺(具体详见公司招股说明书)。感谢您对公司的关注!查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-08-16/doc-incivrre5675655.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-08-16/doc-incivrre5675655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2459315236","title":"金凯生科(301509)8月15日主力资金净卖出1091.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459315236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459315236?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:21","pubTimestamp":1723771307,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月15日收盘,金凯生科报收于29.09元,下跌1.59%,换手率4.77%,成交量2.7万手,成交额7908.36万元。近5日资金流向一览见下表:金凯生科融资融券信息显示,融资方面,当日融资买入572.4万元,融资偿还743.5万元,融资净偿还171.1万元。金凯生科主营业务:为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600015028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2459169771","title":"金凯生科(301509)8月13日主力资金净卖出1126.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459169771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459169771?lang=zh_cn&edition=full","pubTime":"2024-08-14 09:24","pubTimestamp":1723598642,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月13日收盘,金凯生科报收于30.0元,下跌2.06%,换手率5.15%,成交量2.92万手,成交额8701.82万元。近5日资金流向一览见下表:金凯生科融资融券信息显示,融资方面,当日融资买入605.53万元,融资偿还834.12万元,融资净偿还228.59万元。金凯生科主营业务:为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400016544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2459392706","title":"金凯生科:截至2024年8月9日,公司股东总户数为14,631户","url":"https://stock-news.laohu8.com/highlight/detail?id=2459392706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459392706?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:04","pubTimestamp":1723543467,"startTime":"0","endTime":"0","summary":"证券之星消息,金凯生科08月13日在投资者关系平台上答复投资者关心的问题。投资者:请问截止到8月9日收盘公司在册股东人数是多少?公司目前在手项目不涉及相关疾病领域。公司已经关注到相关新闻,相关事件目前对公司没有影响。截至2024年8月9日,公司股东总户数为14,631户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300036146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2459257169","title":"【金凯生科:巴斯夫火灾相关事件目前对公司销售无影响】金十数据8月13日讯,金凯生科8月13日在互动平台回应投资者“金凯生科为巴斯夫等跨国化工集团提供从产品试验到商业化应用所需农药中间体的配套研发和生产服务。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459257169","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459257169?lang=zh_cn&edition=full","pubTime":"2024-08-13 16:40","pubTimestamp":1723538415,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2458301502","title":"金凯生科(301509)8月8日主力资金净卖出1998.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458301502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458301502?lang=zh_cn&edition=full","pubTime":"2024-08-09 09:18","pubTimestamp":1723166322,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月8日收盘,金凯生科报收于30.75元,下跌4.21%,换手率8.89%,成交量5.05万手,成交额1.58亿元。近5日资金流向一览见下表:金凯生科融资融券信息显示,融资方面,当日融资买入1503.62万元,融资偿还850.25万元,融资净买入653.37万元,连续3日净买入累计1225.77万元。金凯生科主营业务:为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900014559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2457853021","title":"A股异动丨金凯生科跌超6% 2662.93万股限售股今日解禁金凯生科(301509.SZ)跌幅扩大至超6%,现报32元,总市值38.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457853021","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457853021?lang=zh_cn&edition=full","pubTime":"2024-08-07 11:20","pubTimestamp":1723000835,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","399300","159982","301509"],"gpt_icon":0},{"id":"2457683181","title":"A股医药股集体走弱 CRO方向领跌河化股份、百花医药跌停,睿智医药、双成药业、金凯生科、鲁抗医药、四环生物、舒泰神等多股跌超5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457683181","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457683181?lang=zh_cn&edition=full","pubTime":"2024-08-07 09:48","pubTimestamp":1722995301,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301509","BK1515","600721","BK0168","399300","BK0216","300204","BK0102","BK0145","159982","BK0188","BK0066","BK0239","000518","159938","BK1161","BK0004","BK0010","BK0077","BK0028","09939","300149","000953","BK0071","002693","BK0046","BK1574","600789","BK0086"],"gpt_icon":0},{"id":"2457780887","title":"76.46亿元市值限售股今日解禁,华虹公司、金凯生科、上海凤凰解禁市值居前周三(8月7日),共有8家公司限售股解禁,合计解禁量为2.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457780887","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457780887?lang=zh_cn&edition=full","pubTime":"2024-08-07 08:16","pubTimestamp":1722989781,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0214","688347","BK0059","BK0165","301509","BK0239","BK0011","BK0184","BK0279","600679"],"gpt_icon":0},{"id":"2457988034","title":"76.46亿元市值限售股今日解禁,华虹公司、金凯生科、上海凤凰解禁市值居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2457988034","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457988034?lang=zh_cn&edition=full","pubTime":"2024-08-07 08:12","pubTimestamp":1722989520,"startTime":"0","endTime":"0","summary":"Wind数据显示,周三,共有8家公司限售股解禁,合计解禁量为2.54亿股,按最新收盘价计算,合计解禁市值为76.46亿元。从解禁市值来看,3家公司解禁股数超亿元。华虹公司、金凯生科、上海凤凰解禁市值居前,解禁市值分别为63.51亿元、9.08亿元、2.39亿元。金凯生科、华虹公司、上海凤凰解禁比例居前,解禁比例分别为22.11%、10.92%、4.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-07/doc-inchukkh7318406.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-07/doc-inchukkh7318406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0059","BK0239","301509","BK0279","BK0214","BK0011","BK0165","BK0184","688347","600679"],"gpt_icon":0},{"id":"2457871758","title":"金凯生科(301509)2662.93万股限售股将于8月7日解禁,占总股本22.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457871758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457871758?lang=zh_cn&edition=full","pubTime":"2024-08-07 08:02","pubTimestamp":1722988960,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,金凯生科于8月7日将有2662.93万股限售股份解禁,为公司首发原股东限售股份,占公司总股本22.11%。最近一年内,该股累计解禁110.97万股,占总股本的0.92%。本次解禁后,公司还有6370.57万股限售股份,占总股本52.89%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700013830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2457090328","title":"金凯生科:公司会严格遵守IPO时签署的稳定股价的相关承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2457090328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457090328?lang=zh_cn&edition=full","pubTime":"2024-08-06 17:04","pubTimestamp":1722935049,"startTime":"0","endTime":"0","summary":"证券之星消息,金凯生科08月06日在投资者关系平台上答复投资者关心的问题。投资者:公司8月5日解禁股上市后是否已满足回购要求?公司会立即启动回购程序吗?公司会严格遵守IPO时签署的稳定股价的相关承诺。公司历次增资情况详见公司招股说明书。感谢您对公司的关注!本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600034014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2457721894","title":"金凯生科(301509.SZ):2662.93万股限售股将于8月7日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2457721894","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457721894?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:09","pubTimestamp":1722859772,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金凯生科(301509.SZ)公告,公司本次申请上市流通的限售股份为首次公开发行前已发行的部分股份,共计2662.93万股,占公司总股本的22.1088%。该部分限售股将于2024年8月7日上市流通。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301509","BK0239"],"gpt_icon":0},{"id":"2457572163","title":"【金凯生科(301509.SZ):2662.93万股限售股将于8月7日上市流通】智通财经APP讯,金凯生科(301509.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457572163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457572163?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:09","pubTimestamp":1722859772,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","301509"],"gpt_icon":0},{"id":"2457761493","title":"A股CRO概念震荡走强 河化股份5连板河化股份5连板,睿智医药涨超10%,百花医药、双成药业、金凯生科、美迪西、昭衍新药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457761493","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457761493?lang=zh_cn&edition=full","pubTime":"2024-08-05 09:37","pubTimestamp":1722821870,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159982","BK0004","06127","399300","300149","603127","BK0071","002693","688202","BK0077","BK0010","BK0216","BK1576","BK0066","000953","301509","BK0102","BK1141","BK0239","600721"],"gpt_icon":0},{"id":"2457761910","title":"CRO板块持续活跃,睿智医药涨超11%,金凯生科、美迪西、泰格医药涨超2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457761910","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457761910?lang=zh_cn&edition=full","pubTime":"2024-08-05 09:34","pubTimestamp":1722821668,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0216","688202","LU1146622755.USD","BK0239","LU1820825898.SGD","BK0174","BK0028","300347","301509","BK1583","300149","BK0077","03347","BK1576","BK1141"],"gpt_icon":0},{"id":"2457615769","title":"金凯生科(301509)8月2日主力资金净卖出106.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457615769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457615769?lang=zh_cn&edition=full","pubTime":"2024-08-05 09:11","pubTimestamp":1722820292,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月2日收盘,金凯生科报收于32.65元,上涨6.08%,换手率21.91%,成交量6.6万手,成交额2.21亿元。近5日资金流向一览见下表:金凯生科融资融券信息显示,融资方面,当日融资买入1692.6万元,融资偿还1541.78万元,融资净买入150.82万元。金凯生科主营业务:为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500002504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301509"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2023-08-03","address":"辽宁省阜新市阜新蒙古族自治县伊吗图镇氟化工园区安仁路6号","stockEarnings":[{"period":"1week","weight":-0.1076},{"period":"1month","weight":-0.129},{"period":"3month","weight":-0.282},{"period":"6month","weight":-0.4494},{"period":"1year","weight":-0.491},{"period":"ytd","weight":-0.4127}],"companyName":"金凯(辽宁)生命科技股份有限公司","boardCode":"AI0027","perCapita":"4290股","boardName":"医药制造业","registeredCapital":"12044万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 金凯(辽宁)生命科技股份有限公司的主营业务为全球知名原研药厂的新药研发项目提供小分子药物中间体以及少量原料药的定制研发生产服务。公司主要产品包括含氟类产品、非含氟类产品等。公司曾获得专精特新“小巨人”企业、高新技术企业、省级企业技术中心等。","serverTime":1724566632113,"listedPrice":56.56,"stockholders":"13225人(较上一季度减少9.61%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金凯生科,301509,金凯生科股票,金凯生科股票老虎,金凯生科股票老虎国际,金凯生科行情,金凯生科股票行情,金凯生科股价,金凯生科股市,金凯生科股票价格,金凯生科股票交易,金凯生科股票购买,金凯生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金凯生科(301509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金凯生科(301509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}